Two types of urgent use of vaccines from Chinese and British pharmaceutical companies were approved in Brazil in South America on the 17th, and vaccination in China began in the largest city of São Paulo.
In Brazil, two types of vaccines were approved for emergency use by Chinese pharmaceutical company "Sinovac" and British pharmaceutical giant "AstraZeneca" on the 17th, and in the largest city of São Paulo, Sinovac vaccination is ahead of other regions. It started for medical professionals.
According to the Brazilian government, Sinovac vaccines are cheaper than Western vaccines, and the Chinese side is also supportive of providing data and ensuring safety.
In Brazil, the cumulative number of infected people is about 8.4 million and the death toll is over 200,000, and there are increasing calls for early start of vaccination.
The Brazilian government wants to expand vaccination in the future, but it has not yet secured enough vaccine to reach a population of over 200 million people, which is a big issue for future vaccination.